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Abstract 
It has been pointed out that close homolog of L1 (CHL1) and its truncated form mainly 
play crucial roles in mouse brain development and neural functions. Herein, we newly 
identified that truncated form of CHL1 is produced and released from lung tumor tissue 
in a mouse model expressing human EML4-ALK fusion gene. The primary tumor cells 
derived from lung tumor tissues secreted CHL1 into culture medium. The secretion of 
truncated form of mouse CHL1 was also observed in HEK293 cells transiently 
expressed mouse CHL1. Both western blot and direct ELISA analysis revealed that 
serum levels of secreted mouse CHL1 were significantly elevated in EML4-ALK 
transgenic mice compared with that in wild-type mice. A part of secreted CHL1 into 
mouse serum appeared to be included in extracellular vesicles (E.V.). The correlation 
between the tumor mass and the amount of CHL1 secretion in 40 wild-type and 40 
transgenic mice was examined, and showed a significant positive correlation. These 
findings demonstrated that the secretion of CHL1 occurred in not only the brain but also 
tumor cells resulting in the increase of circulating CHL1 levels in a tumor size-
dependent manner. Considering that EML4-ALK transgenic mouse used in this study is 
a human lung cancer model, measurement of circulating CHL1 level may contribute to 
the diagnosis of human lung cancer. 
Keywords: Closed homolog of L1, Lung cancer, EML4-ALK gene, tumor marker 
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Introduction
A lot of molecules (genes) overexpressed in tumor tissues compared with 
normal tissues have been a concern in the oncology research, and often used as the 
targets for tumor diagnosis. Among them, secretory proteins, shedding forms of 
membrane proteins and extracellular vesicles (E.V.; e.g. exosomes) recently emerged [1] 
are secreted from tumor tissues into blood, and used for diagnosis as a serum tumor 
markers [2–4].
Close homolog of L1 (CHL1) is a type I transmembrane protein, and belongs to 
immunoglobulin superfamily [5,6], and is expressed in several mammalian species. The 
physiological function of CHL1 has been studied, and is mainly involved in the neural 
development and functions in mice [6–11]. On the other hand, CHL1 plays an important 
contribution in tumor cells such as breast cancer [12] and glioma [13]. Indeed, CHL1 is 
upregulated at the transcriptional level in several tumor cells [14]. There is no doubt that 
CHL1 is a remarkable molecule in tumor biology. 
Despite a membrane protein, CHL1 has also been reported to suffer an 
ectodomain shedding by various proteases in brain tissues and nerve cells resulting in 
secretion outside a tissue (cell) as a its soluble form [15]. This ectodomain shedding is 
catalyzed by several proteases, ADAM family proteases and BACE 1 [16,17], which 
involved in the production of A-beta peptide in Alzheimer's disease [18–22]. 
Particularly, ectodomain shedding of CHL1 by BACE1 has attracted attention, because 
the physiological functions of CHL1 have been studied in brain tissues and nerve cells. 
However, secretion of CHL1 molecule accompanying ectodomain shedding reaction of 
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CHL1 in cancer tissue (cell) has not been studied. In particular, considering the serum 
tumor marker described above, there is no doubt it is an important finding.
Here we examined the secretion of mouse CHL1 molecule (mCHL1) from 
tumor tissue (cell) by ectodomain shedding using an animal model, EML4-ALK 
transgenic mouse [23]. EML4-ALK transgenic mice carry human EML4-ALK fusion 
gene [24] allele in the lung, and is an early carcinogenic mouse model in which lung 
tumor is formed at 4 weeks of age. It is, therefore, useful not only for research on lung 
cancer development by the fusion gene but also for that on onco-biochemistry. In the 
previous study, we identified both gene expression and protein expression of CHL1 
were elevated in the tumor tissue derived from EML4-ALK transgenic mouse (Kotani et 
al., in preparation). We measured the CHL1 protein levels secreted into the culture 
medium of primary cells established from the tumor tissue in EML4-ALK transgenic 
mouse and the serum levels of secreted CHL1 protein in wild-type mouse and EML4-
ALK transgenic mouse at each week of age. Our findings revealed that CHL1 is secreted 
from the tumor tissue (cell), and is increased in the serum of tumor-bearing EML4-ALK 
transgenic mouse compared with that of wild-type mice.
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Materials and Methods
Animals 
C57BL/6J mice were obtained by self-breeding of the pair mice purchased from Japan 
CLEA Co. (Tokyo, Japan), and were maintained under specific pathogen-free conditions 
at 20-25 °C in accordance with the Saitama Medical University Animal Experiment 
Committee (protocol number 2162). The EML4-ALK transgenic mouse [23] were 
maintained under specific pathogen-free conditions at 20-25 °C in accordance with the 
Saitama Medical University Animal Experiment Committee (protocol number 2158 and 
2162) and the Saitama Medical University Safety Committee for Recombinant DNA 
Experiments (protocol number 1360). All animals were maintained under a 12-hr light/ 
12-hr dark exposure and free access to food and water.
Collection of tumor tissue and serum samples from mice
Seven to forty-three weeks old mice (Supporting Table 1) were deeply anesthetized with 
isoflurane and then sacrificed by cervical dislocation. After blood sampling from the 
heart, serum was prepared using a dedicated blood sampling tube (Fuchigami Co., 
Kyoto, Japan). Then, the tumor tissues of EML4-ALK transgenic mice were excised and 
weighed.
Preparation of primary cells from tumor tissue
The lung tumor tissues were minced and treated with collagenase (Worthington 
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Biochemical, NJ) in sterile PBS solution at 37 °C for 30min. The large debris were 
removed from the mixture, and then washed 3 times with RPMI 1640 medium (Wako 
Chemicals, Osaka, Japan). The cells were seeded at collagen-coated 10 cm dishes 
(IWAKI glass, Shizuoka, Japan) with RPMI 1640 medium supplemented with 10 % 
fetal bovine serum (FBS; GIBCO, MA; Cat. No. 12483-020) at 37 °C under humidified 
air containing 5 % CO2 (approx. 200 µg of minced tissues per 10 cm dishes). The next 
day, medium was replaced with new medium followed by cultivation for 3 days. 
Subsequent medium change was performed, continued to culture for 2 days. The 
cultured medium was recovered as the conditioned medium. The cultured cells and 
conditioned medium were both collected respectively for the measurement of cellular 
and secreted mCHL1.
Expression of fluorescent tag-conjugated CHL1 in HEK293 cells
 The cDNA of mCHL1 was cloned by assembly of PCR fragments amplified using 
EmeraldAmp® PCR Master Mix (Takara Bio, Shiga, Japan) based on the mouse lung 
tumor cDNA library established using tumor tissues of EML4-ALK transgenic mice. The 
sequences of PCR primers used in the PCR cloning were as follows: forward 5’-
cgcgcggccgcatgatggaattgccattatg-3’ and reverse 5’-caaaacactcgagcaatagtgta-3’ for “Xho 
I region”; forward 5’-tacactattgctcgagtgttttg-3’ and reverse 5’-catctcaaaagcttctccatctt-3’ 
for “Xho I-Hind III region”; forward 5’-aagatggagaagcttttgagatg-3’ and reverse 5’-
caccaat t ta tctggtaccctct-3’ for “Hind III-Kpn I region”; forward 5’-
agagggtaccagataaattggtg-3’ and reverse 5’-cgcgaattctgcccggagtgggaaggtgg-3’ for “Kpn 
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I region”. The cDNA of both mCHL1 and fluorescent tag (EGFP, Azami green, or 
mCherry) were inserted into pcDNA 3.1 (+) expression vector (Fig. 1C; Thermo Fisher 
Scientific, MA), then the resulting vector was transfected into HEK293 cells. The 
transfectant cells were cultured for 3 days with RPMI 1640 medium supplemented with 
5 % FBS at 37 °C under humidified air containing 5 % CO2. The observation of protein 
expression was performed using EVOS FLoid® Cell Imaging Station fluorescence 
microscopy (Thermo Fisher Scientific, MA) equipped with green and red fluorescence 
channels. The cultured cells and conditioned medium were both collected respectively.    
 
Separation of extracellular vesicles from mouse serum
Twenty-five µl of each serum sample was mixed with 6.3 µl of ExoQuick exosome 
precipitation solution (System Biosciences, CA), and incubated at 4 °C for 15 min. 
After centrifugation at 1,500 g for 15 min, serum component (without E.V.) was 
separated from the precipitates (including E.V.). The precipitates were resolved with 50 
µl of PBS.
Western blot analysis
The conditioned medium obtained by primary lung tumor cell culture and mCHL1 
transfectant HEK293 cells was concentrated by using Nanosep® Centrifugal Devices 
(30 kDa cut-off, Pall Co., NY). The concentrated residues and cell lysates were 
subjected to SDS-PAGE (6 % gel), then transferred to an Immobilon®-P PVDF 
Membrane (Merck Millipore, Germany). After blocking with 5 % skim milk solution, 
the membrane was treated with anti-mCHL1 antibody (AF2147; R&D systems, MN; 1 
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µg/ml) at room temperature for 1 hr followed by goat TrueBlot®: anti-goat IgG HRP 
(Rockland, PA; 1:1000 dilution) at room temperature for 1 hr. In the case of mCHL1-
transfected HEK293 cells, the membrane was treated with HRP-conjugated anti-
mCHL1 antibody, which was labeled by using peroxidase labeling kit-SH (Dojindo, 
Kumamoto, Japan), at room temperature for 1 hr (1:3000 dilution). For the detection of 
fluorescent protein tag, the resulting membrane was treated with anti-GFP antibody or 
anti-Azami Green antibody (MBL life science, Nagoya, Japan; 1:1000 dilution) at room 
temperature for 1 hr followed by the treatment with HRP-conjugated anti-rabbit IgG 
(Promega; 1: 5000). The 2µl of serum samples and EV solutions described above were 
similarly subjected to 6 % SDS-PAGE gel, then transferred to a PVDF Membrane. After 
blocking with 5 % skim milk solution, the membrane was treated with HRP-conjugated 
anti-mCHL1 antibody (1:3000 dilution) at room temperature for 1 hr. After antibody 
treatment of these membranes, the membrane was developed with an Immobilon 
Western Chemiluminescent HRP Substrate (Merck Millipore, Germany). The 
membrane was exposed and analyzed using ChemiDoc MP image analyzer (BIO-RAD, 
CA).
Direct ELISA 
The serum samples were therefore diluted 50-fold with PBS, subsequently applied to 
96-well ELISA plates (CORNING, NY; No. 3369), and then incubated at 37 °C for 1 hr. 
After washing with 0.05 % Tween-PBS solution, each well was treated with 5 % skim 
milk solution at 37 °C for 1 hr for blocking. The 5 % skim milk solution containing 
HRP-conjugated anti-mCHL1 antibody (1:3000 dilution) was added to each well, and 
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incubated at 37 °C for 1 hr. After gentle washing, HRP substrate solution (SureBlue 
Reserve; SeraCare, MA) was added and developed at room temperature for 10 to 20 
min. Twenty µl of 1N HCl solution was then added to each well followed by the 
measurement of O.D. 450 nm. In order to compare the data among each experimental 
plate, a representative sample was selected in each plate followed by the measurement 
of each representative sample in the same plate at a later date. To compensate the 
differences among ELISA plates, the relative values were determined based on the 
above results as “Relative index”.   
Statistical analysis
The statistical analyses and receiver operating characteristic (ROC) curve analysis were 
performed using R software (The R Foundation for Statistical Computing, Austria) and 
EZR (Saitama Medical Center, Jichi Medical University, Japan), which is a graphical 
user interface for R. Statistical significance test of relative index of serum CHL1 level 
between wild-type mice and EML4-ALK transgenic mice, and between male and female, 
were performed with Mann-Whitney test. We used a statistical significance level of 0.05 
or smaller. Similarly, the correlation of age vs. serum CHL1 level and tumor mass vs. 
serum CHL1 level were indicated using Spearman's rank correlation coefficient.
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Results
In vitro secretion of mCHL1 from tumor primary cells 
Since tumor tissues of EML4-ALK transgenic mice infiltrated into the normal 
lung tissue, tumor tissue mass was carefully dissected from whole lung tissue. The 
primary lung tumor cells established from tumor tissue mass rapidly proliferated (Fig. 
1A). By the western blot analysis, truncated form of mCHL1 was observed in the 
conditioned medium (Fig. 1B, lane “S”), demonstrating that mCHL1 was secreted 
extracellularly resulting from some processes. Several bands other than initially 
expected band were observed in the cellular mCHL1 (Fig. 1B, lane “C”). This 
phenomenon was also observed in the cells harvested within 24 hr after subsequent 
medium change (Data not shown).   
Because the cellular mCHL1 seemed to be decomposed, we also confirmed 
whether systematic ectodomain shedding of mCHL1 occurred under our experimental 
condition. The cultivation of HEK293 cells expressed fluorescent protein-tagged 
mCHL1 (Fig. 1C and 1D) revealed that small molecular weight of mCHL1 as a 
truncated form mCHL1 was obviously detected in the supernatant without severe 
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degradation of cellular fluorescent protein-tagged mCHL1 (Fig. 1E). Also, we examined 
whether the shedding domain of mCHL1 existed in extracellular region of mCHL1 as 
previously reported [15]. Almost the fluorescent protein tag remained in the cellular 
component (Fig. 1F), suggesting that mCHL1 was disconnected in extracellular region. 
These observations were not affected by the type of fluorescent protein tag (Fig. 1D, 1E 
and 1F).         
Detection of mCHL1 in serum from lung tumor-bearing mouse 
In vitro experiment described above encouraged us to make the following 
measurement of circulating tumor-derived mCHL1 in EML4-ALK transgenic mice. The 
western blot analyses of serum samples indicated that although mCHL1 was detectable 
in both serum samples from wild-type and EML4-ALK transgenic mice, strong signal 
bands were observed in the serum samples from EML4-ALK transgenic mice compared 
with wild-type mice (Fig. 2A).  
In addition, it was suggested based on the experiments using HEK293 
expression system that both truncated form mCHL1 and very faint full length mCHL1 
were also contained in serum. Therefore, the serum E.V including full length mCHL1, 
which was isolated from each serum samples by polymer-based precipitation method, 
and remaining serum components were analyzed, respectively. It was found that 
mCHL1 was present not only in serum component but also in exosome, and its 
abundance ratios between E.V. fraction and remaining serum component were different 
from each other (Fig. 2B). 
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Measurement of mCHL1serum levels by direct ELISA  
For accurate and sensitive measurement of mCHL1 in serum samples, direct 
ELISA was performed using anti-mCHL1 antibody. The optimal dilution ratio was 
determined by preliminary experiment (Supporting Fig. 1). It was found that the 
reactivity was improved by using the diluted serum to some extent. As a result of 
measurement using 50-fold dilution sample of serum in this assay system, the relative 
indexes in serum samples of 40 wild-type mice were indicated as approximately 0.05 or 
less (Fig. 3A). In contrast to this, a lot of relative index of 40 EML4-ALK transgenic 
mouse was more than 0.05, with some samples exceeding 0.1 (Fig. 3B). The mean value 
of the relative index in wild-type mice was found to be 0.0187 (S. D. = 0.0105), and that 
in EML4-ALK transgenic mice was found to be 0.0633 (S. D. = 0.0586). Since the p 
value was small (1.801 x 10-9), there was a significant difference in serum mCHL1 level 
between wild-type and EML4-ALK transgenic mice (Fig. 3C). Moreover, serum mCHL1 
levels were compared between males and female of EML4-ALK transgenic mice, 
indicating that female mice had significantly higher mCHL1level than that in male mice 
(Fig. 3D; TG). On the other hand, in wild-type mice, the significant difference between 
male and female was not observed (Fig. 3D; WT). Based on the ROC curve of each 
serum level of mCHL1, area under the curve (AUC) and cut-off value were calculated 
as 0.865, and 0.0293, respectively (Fig. 3E).
Correlation between tumor mass and serum mCHL1 level 
By Spearman's rank correlation analysis, a significant correlation was observed 
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between serum mCHL1 level and tumor mass (Fig. 4A), suggesting that the mCHL1 
secretion and the elevation of its serum level occurred in a tumor-dependent manner. 
Interestingly, a significant correlation between serum mCHL1 level and age at week 
was observed in wild-type mice (Fig. 4B; Upper column), but no correlation was 
observed in EML4-ALK transgenic mice (Fig. 4B; Lower column).   
4. Discussion
The typical lung cancer model mice frequently used are transplantation models 
in nude mice inoculated with other lung tumor cells. Unlike these typical model mice, 
there are advantages in EML4-ALK transgenic mice that can examine, for instance, the 
tumor growth and serum protein markers in young age. Here we first established the 
primary cells that can be reproducibly generated from the tumor tissues derived from 
EML4-ALK transgenic mice. The primary cell has a high proliferative ability, and is 
considered to represent well the state of lung tumor cells initiated by EML4-ALK fusion 
gene. There has been no report on the event that CHL1 is highly expressed in human 
EML4-ALK-positive lung tumor and is secreted from tumor cells (tissue) until now, 
whereas we first showed at least its truncated form is secreted extracellularly from the 
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primary cells. On the other hand, the gene expression omnibus (GEO) profile of the 
human lung cancer cell line in the NCBI database showed that some human lung cancer 
cell lines (e.g. LK2 cells) moderately expressed CHL1 molecule (data not shown). From 
these facts, it is suggested that modulate expression of CHL1 may be observed in lung 
tumor in general rather than in specific lung tumor.     
Unlike the secreted form, cellular mCHL1 was detected as various fragments 
(Fig. 1B), implying that there are many proteases in this tumor primary cells (e.g. 
ADAM family proteases [15,22]), which are capable of cleaving mCHL1 at several 
domain. It was not clear whether BACE1 contributed to the cleavage of mCHL1 
observed in primary lung tumor cells established in this study. According to the gene 
expression profile of EML4-ALK transgenic mice tumor tissue (Kotani et al., in 
preparation), the gene expression of BACE1 was not significantly different from that of 
normal lung tissue (Data not shown). 
A truncated form mCHL1 shorter than the full length mCHL1 was detected in 
the culture supernatant of the primary cell. Simultaneously, in HEK293 expression 
experiments, almost fluorescent tag was detected in intracellular mCHL1 but not little in 
secreted form mCHL1 (Fig. 1E and 1F). These indicated that most secreted mCHL1 
does not contain cytoplasmic region due to cleavage at the extracellular domain of 
mCHL1 as described in previous research [15]. On the other hand, the faint signals of 
full-length mCHL1 including fluorescent protein tag were detected (Fig. 1E and 1F). It 
was postulated that full-length mCHL1 was included in the recently noted extracellular 
vesicles (e.g. exosome), which was secreted from the tumor cell (tissue). 
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Based on the results of in vitro experiments described above, we speculated that 
mCHL1 secreted from tumor cells was released into the blood stream resulting in 
circulating whole body. By the western blot analyses of mCHL1 in sampling serum, 
mCHL1 was detected both in wild-type and EML4-ALK transgenic mouse serum (Fig. 
2A). In wild-type mice, these have been considered to secrete from normal tissues such 
as brain tissues as reported previously [6]. By the isolation of E.V. from serum samples, 
it was also interesting that the mCHL1 in E.V. was strongly detected in a part of serum 
samples of EML4-ALK transgenic mouse (Fig. 2B). In general, the E.V. secreted from 
tumor tissue has been said to show special features compared with that from normal 
tissues [25], however, the functions of CHL1-expressing E.V. from lung tumor tissue 
detected in this study is unknown. 
In order to quantitatively examine a serum level of mCHL1, a direct ELISA was 
carried out due to simple manipulation and the difficulty to obtain an appropriate 
mCHL1 capture antibody used in a sandwich ELISA. The variability observed in the 
data was thought to be influenced by the dependence on the size of lung tumor in 
EML4-ALK transgenic mouse (Fig. 4A). The correlation between tumor mass and 
mCHL1 serum levels also indicated that the increase serum level of mCHL1 was tumor-
dependent phenomenon. Similar report mentioned that the correlation between the 
elevation of cleavage protein and tumor volume in breast cancer model mouse [26]. In 
addition to this, the correlation between age and serum mCHL1 level observed in wild-
type mice (Fig. 4B, Upper column) was canceled in EML4-ALK transgenic mouse (Fig. 
4B, Lower column), suggesting that the age-dependent increase in serum mCHL1 level 
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observed in wild-type mice could be disturbed by tumor formation. Interestingly, it was 
found that there was a gender difference in the extent of increase of mCHL1 serum level 
through lung tumor formation by unknown mechanism (Fig. 3D). There was no 
significant difference in the tumor mass between male and female EML4-ALK 
transgenic mice (data not shown). Considering these results, it was speculated that 
female tumor tissue secretes more mCHL1 molecules compared to male tumor tissues.  
Previous studies have tried to find the tumor markers using mouse tumor model 
[26–28]. As revealed in this study, mouse lung tumor transformed by the human EML4-
ALK fusion gene secretes mCHL1 molecules resulting in the elevation of serum 
mCHL1 level. Also, ROC curve analysis for EML4-ALK transgenic mouse revealed 
serum mCHL1 level was an excellent indicator for lung tumor. However, it remains 
unclear that the phenomenon in this study can actually be observed in human lung 
cancer patients. First, the tumor tissues in EML4-ALK transgenic mouse used in this 
study seems to be relatively larger than that in typical lung tumor-bearing patient, 
therefore, it is unknown whether an elevation of serum mCHL1 level observed in 
EML4-ALK transgenic mouse is also reproduced in human lung tumor patients. In 
practice, young mice (7 weeks old) with small tumors (mouse No. 38, 39, 40) showed 
low levels of serum mCHL1 (Fig. 3B). Similarly, it is necessary to consider that 
mCHL1 elevation is in the whole lung tumor patient, or is a phenomenon specific to 
EML4-ALK lung cancer patient, which is about 5 % of whole lung cancer patients. By 
these confirmations, we can assess the usefulness of measurement of human serum 
mCHL1 level as an indicator in lung tumor. 
16
© 2018. This manuscript version is made available under the CC-BY-NC-
ND 4.0 license hAp://creaDvecommons.org/licenses/by-nc-nd/4.0/ 
Acknowledgements
We thank Professor Hiroyuki Mano and Dr. Manabu Soda for providing EML4-ALK 
transgenic mouse; This work was supported by Grants-in-aid for Scientific Research in 
17
© 2018. This manuscript version is made available under the CC-BY-NC-
ND 4.0 license hAp://creaDvecommons.org/licenses/by-nc-nd/4.0/ 
Japan (No. JP24590082 and No. JP15K07941) (to N. K.), and Mizutani foundation 
research grants (to N. K.). The authors declare that they have no conflicts of interest 
with the contents of this article.
Figure Legends
Fig. 1 Ectodomain shedding of mouse CHL1 
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(A) A representative image of primary tumor cells established from lung tumor tissue in 
EML4-ALK transgenic mouse. Bar; 100 µm. (B) Western blot analysis of truncated form 
of mCHL1 secreted into culture supernatant. Mouse CHL1 (mCHL1) was detected by 
using anti-mCHL1 antibody as described in “Materials and Methods”. White arrows 
indicate the putative mCHL1 fragments. Black arrow indicates the truncated mCHL1 
molecule. C; Cell lysate, S; Culture supernatant. (C) Expression vector of fluorescent 
tag-conjugated mCHL1. The fluorescent protein tags (EGFP, Azami Green, and 
mCherry) were inserted into the C-terminal position of mCHL1. (D) Expression of 
fluorescent tag-conjugated mCHL1 in HEK293 cells detected by fluorescent microscopy 
(Upper column; fluorescein, Lower column; phase contrast). EGFP (Left), Azami Green 
(AG; Middle), and mCherry (Right)-conjugated mCHL1 were expressed by above 
expression vector. White bar located in lower right; 100 µm. (E) Western blot analysis 
of fluorescent tag-conjugated mCHL1. Each fluorescent tag-conjugated mCHL1 
expressed in the cells and secreted in culture supernatant was subjected to Western blot 
analysis using anti-mCHL1-HRP antibody. (F) Western blot analysis of EGFP or Azami 
Green-conjugated mCHL1. Each fluorescent tag-conjugated mCHL1 expressed in the 
cells and secreted in culture supernatant was subjected to Western blot analysis using 
anti-EGFP or anti-Azami Green antibody. C; Cell lysate, S; Culture supernatant.
 Fig. 2 Detection of serum mCHL1 in wild-type and lung tumor-bearing mouse
(A) Western blot analysis of mCHL1 in mouse serum obtained from wild-type (WT) 
and EML4-ALK transgenic (TG) mouse. Each mouse serum (2 µl) was subjected to 
Western blot analysis using anti-mCHL1-HRP antibody. (B) Detection of mCHL1 in 
19
© 2018. This manuscript version is made available under the CC-BY-NC-
ND 4.0 license hAp://creaDvecommons.org/licenses/by-nc-nd/4.0/ 
extracellular vesicles (E.V.) including wild-type (WT) and EML4-ALK transgenic (TG) 
mouse serum. Each serum was treated with ExoQuick exosome precipitation solution 
described in “Materials and Methods”. The precipitated E.V. fractions (Upper column; 
E.V.) and remaining serum component (Lower column; Serum without E.V.) were 
subjected to Western blot analysis using anti-mCHL1-HRP antibody. Arrows indicate 
the bands of mCHL1.
Fig. 3 Increase of serum mCHL1 level in lung tumor-bearing mouse
 (A, B) Direct ELISA analysis of serum mCHL1. The serum collected from 40 mice of 
wild-type (A) and EML4-ALK transgenic mice (B) were applied to the direct ELISA 
analysis for the calculation of “Relative Index” as described in “Materials and 
Methods”. (C) Comparison of serum mCHL1 levels between wild-type (WT) and 
EML4-ALK transgenic (TG) mouse. The serum mCHL1 level of EML4-ALK 
transgenic mouse was significantly higher than that of wild-type mouse (p=1.80x10-9). 
(D) Gender differences of serum mCHL1 levels observed in EML4-ALK transgenic 
mouse. There was no significant difference of serum mCHL1 level between male and 
female in wild-type mouse (n.d.), in contrast, significant difference was observed in 
EML4-ALK transgenic mouse (p=9.70x10-4). (E) ROC curve for serum mCHL1 level 
of wild-type and lung tumor-bearing EML4-ALK transgenic mouse. AUC = 0.865.
Fig. 4 Correlation between serum mCHL1 level and lung tumor mass
(A) Scatter plot of tumor mass versus relative index. The spearman's rank correlation 
coefficient was 0.692 (p = 7.97x10-6). (B) Scatter plot of mouse age versus relative 
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index in wild-type (Upper column) and EML4-ALK transgenic mouse (Lower column). 
The spearman's rank correlation coefficient was 0.47 (p = 2.23 x10-3) in wild-type 
mouse, and was 0.172 (p = 0.290) in EML4-ALK transgenic mouse. 
Supporting Figure Legends
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Supporting Fig. 1 Preliminary experiment for determining optimal serum dilution  
The serum samples from wild-type (WT) and EML4-ALK transgenic (TG) mouse were 
diluted stepwise. The diluted samples were applied to ELISA plate, and then subsequent 
process was performed according to “Materials and Methods”.
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